Clinical Trials Directory

Trials / Conditions / Pertussis (Whooping Cough)

Pertussis (Whooping Cough)

13 registered clinical trials studyying Pertussis (Whooping Cough) — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (
NCT07492303
Changchun BCHT Biotechnology Co.Phase 1
RecruitingEstablishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis
NCT06827470
Dalhousie UniversityPhase 1
Active Not RecruitingStudy Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant Women
NCT06888076
BioNet-Asia Co., Ltd.—
Active Not RecruitingSafety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination D
NCT06258057
Sanofi—
RecruitingPeriscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks
NCT05847322
University of SouthamptonN/A
CompletedPertussis Challenge Study in Adults Vaccinated With BPZE1
NCT05461131
ILiAD BiotechnologiesPhase 2
CompletedInfluenza and Pertussis Vaccination Status of Women in Immediate Postpartum and Caregivers
NCT05234229
Central Hospital, Nancy, France—
RecruitingThe Optimal Timing of Vaccination in Pregnancy
NCT06466629
Elke Leuridan, MD, PhD—
CompletedEffectiveness of Adacel Vaccination in Pregnancy at Preventing Pertussis in Infants < 2 Months of Age in the U
NCT05040802
Sanofi Pasteur, a Sanofi Company—
CompletedImmunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Todd
NCT07213089
BioNet-Asia Co., Ltd.Phase 2 / Phase 3
CompletedSafety Monitoring of VacPertagen Vaccine in Thailand
NCT07400120
BioNet-Asia Co., Ltd.—
CompletedSafety Monitoring of Boostagen® Vaccine in Thailand
NCT07444502
BioNet-Asia Co., Ltd.—
RecruitingPediatric Pertussis in Ambulatory Settings
NCT04807712
Association Clinique Thérapeutique Infantile du val de Marne—